| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/31/2011 | US7951558 microorganism co-transformed with a recombinant expression vector containing E. coli outer membrane protein F (OmpF) and a recombinant expression vector containing a target protein to be secreted into cell culture broth, as well as a method of secreting and producing the target protein into cell culture |
| 05/31/2011 | US7951557 Human lysosomal proteins from plant cell culture |
| 05/31/2011 | US7951556 Mutated prokaryotic cells with high secretion-levels |
| 05/31/2011 | US7951546 Compositions and methods for the diagnosis and treatment of tumor |
| 05/31/2011 | US7951532 Modulating mammalian midkine activity; alters pulmonary vasculature development and smooth muscle cell development |
| 05/31/2011 | US7951530 Cyclic maltosylmaltose, cyclic maltosymaltose-forming enzyme, their preparation and uses |
| 05/31/2011 | US7951386 Recombinant cytochrome oxidase and/or morula membrane protein for use in developing therapeutics which prevent infection associated with mite parasitfes |
| 05/31/2011 | US7951381 Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor |
| 05/31/2011 | US7951380 Methods of stimulating bone growth using ZVEGF4 polypeptides |
| 05/31/2011 | US7951379 Hollow nanoparticle of NBsAg large protein for drug delivery |
| 05/31/2011 | US7951378 Modified cell adhesion molecule comprising immunoglobulin heavy chain fusion for treatment and prevention of respiratory system disorders |
| 05/31/2011 | US7951375 Methods of inducing an immune response |
| 05/31/2011 | US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling |
| 05/31/2011 | US7951369 Chimeric, human and humanized anti-granulocyte antibodies and methods of use |
| 05/31/2011 | US7951366 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
| 05/31/2011 | US7951361 Transgenic escherichia for which express bacterial surface protein for use in generation of vaccine which prevents coliform bacterial infection; antidiarrhea agents |
| 05/31/2011 | US7951357 Implantable power sources and sensors |
| 05/31/2011 | CA2539168C Optimized expression of hpv 45 l1 in yeast |
| 05/31/2011 | CA2465054C Aequorin as a growth marker in yeast |
| 05/31/2011 | CA2460759C Diagnostic probe detection system |
| 05/31/2011 | CA2438661C Yeast screens for agents affecting protein folding |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2398539C Myeloid colony stimulating factor and uses thereof |
| 05/31/2011 | CA2390312C Oligomer array with pna and/or dna oligomers on a surface |
| 05/31/2011 | CA2339324C Protein delivery system using human papillomavirus virus-like particles |
| 05/31/2011 | CA2323064C Nucleic acid binding proteins |
| 05/31/2011 | CA2237356C Methods for diagnosis and treatment of bloom's syndrome |
| 05/31/2011 | CA2215328C Novel human cytomegalovirus dna sequences |
| 05/26/2011 | WO2011063409A1 Maternally induced sterility in animals |
| 05/26/2011 | WO2011063388A2 Assay method for target nucleic acid by signal amplification using probe hybridization and restriction |
| 05/26/2011 | WO2011063363A2 Production of an organic acid and/or related chemicals |
| 05/26/2011 | WO2011063324A2 Microfluidic systems for isolating microvesicles |
| 05/26/2011 | WO2011063320A2 Recombinant filaggrin polypeptides for cell importation |
| 05/26/2011 | WO2011063284A1 Production of therapeutic proteins in photosynthetic organisms |
| 05/26/2011 | WO2011063263A2 Methods for producing an immune response to tuberculosis |
| 05/26/2011 | WO2011063210A2 Methods of mapping genomic methylation patterns |
| 05/26/2011 | WO2011063157A2 Organic acid production in microorganisms by combined reductive and oxidative tricarboxylic acid cycle pathways |
| 05/26/2011 | WO2011063126A1 Highly dispersible powders, compositions and methods for preparation |
| 05/26/2011 | WO2011063098A2 Genetic markers for weight management and methods of use thereof |
| 05/26/2011 | WO2011063055A2 Engineering microbes for efficient production of chemicals |
| 05/26/2011 | WO2011062997A2 Human monoclonal antibodies to human nucleolin |
| 05/26/2011 | WO2011062859A1 Display of disulfide linked dimeric proteins on filamentous phage |
| 05/26/2011 | WO2011062748A1 Sucrose transporter genes for increasing plant seed lipids |
| 05/26/2011 | WO2011062634A2 Monoclonal antibodies and diagnostic uses thereof |
| 05/26/2011 | WO2011062563A1 Modulators of cell cycle progression |
| 05/26/2011 | WO2011062414A2 Improved autoinduction expression system |
| 05/26/2011 | WO2011062298A1 System for increasing gene expression, and vector supporting said system |
| 05/26/2011 | WO2011062263A1 Pharmaceutical composition |
| 05/26/2011 | WO2011062258A1 Primer set for amplification of mthfr gene, mthfr gene amplification reagent comprising same, and use of same |
| 05/26/2011 | WO2011062207A1 Human artificial chromosome vector |
| 05/26/2011 | WO2011062206A1 Human artificial chromosome vector |
| 05/26/2011 | WO2011062166A1 Method for estimating dynamic state of secondary structure of rna |
| 05/26/2011 | WO2011062155A1 NUCLEIC ACID ENCODING MUTANT Gag PROTEIN |
| 05/26/2011 | WO2011062112A1 Highly-functional mutant of humanized anti-egfr antibody variable region |
| 05/26/2011 | WO2011061937A1 Methods for producing antibody-producing cells that produce desired polypeptides |
| 05/26/2011 | WO2011061849A1 Recombinant measles virus useful as bivalent vaccine against measles and nipah virus infection |
| 05/26/2011 | WO2011061848A1 Recombinant measles virus useful as bivalent vaccine against measles and malaria infection |
| 05/26/2011 | WO2011061702A1 Method for amplifying the pentose phosphate pathway in yeast strains, the resulting yeast and uses thereof |
| 05/26/2011 | WO2011061656A1 Plants with increased yield |
| 05/26/2011 | WO2011061351A1 Aptamers directed against the matrix protein-1 of type a influenza viruses and uses thereof |
| 05/26/2011 | WO2011061336A1 Retroviral vector particles and methods for their generation and use |
| 05/26/2011 | WO2011061274A1 Method for selectively enriching and isolating microbial and optionally additional viral nucleic acids |
| 05/26/2011 | WO2011061244A1 Novel phage display vector |
| 05/26/2011 | WO2011061194A1 Inhibitors of centrosomal clustering |
| 05/26/2011 | WO2011060946A1 Brassica plants comprising mutant fad3 alleles |
| 05/26/2011 | WO2011060920A2 Process for the production of fine chemicals |
| 05/26/2011 | WO2011060613A1 Human alpha-defensin 5 mutant polypeptide and preparation method and use thereof |
| 05/26/2011 | WO2011060599A1 Small interfering rna(sirna) which can specifically inhibit expression of echs1 gene and use thereof |
| 05/26/2011 | WO2011060583A1 Nonnatural collagen-like protein and use thereof |
| 05/26/2011 | WO2011060557A1 Method for selection of aptamers |
| 05/26/2011 | WO2011060552A1 Variegation in plants |
| 05/26/2011 | WO2011060534A1 Trim5alpha mutants and uses thereof |
| 05/26/2011 | WO2011060490A1 Angiogenin expression in plants |
| 05/26/2011 | WO2011060489A1 Transgenic non-human animals |
| 05/26/2011 | WO2011060488A1 Recombinant microorganisms |
| 05/26/2011 | WO2011041584A3 Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
| 05/26/2011 | WO2011033061A3 Method for the production of recombinant proteins by green microalgae |
| 05/26/2011 | WO2011009132A3 Methods and composition for isoprenoid diphosphate synthesis |
| 05/26/2011 | WO2011008092A3 Gram-positive bacteria specific binding compounds |
| 05/26/2011 | WO2011004957A3 Probe for detecting the resistance of mycobacterium tuberculosis to drugs, and kit for same |
| 05/26/2011 | WO2011002239A3 Microvesicles derived from nucleated, mammalian cells and use thereof |
| 05/26/2011 | WO2010143055A3 Inhibition-based high-throughput screen strategy for cell clones |
| 05/26/2011 | WO2010135329A3 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor |
| 05/26/2011 | WO2010124101A3 Genetic markers associated with endometriosis and use thereof |
| 05/26/2011 | WO2010120541A3 Compositions and methods for modulating the activity of complement regulatory proteins on target cells |
| 05/26/2011 | WO2010120143A3 Marker for prognosis of liver cancer |
| 05/26/2011 | WO2006119449A3 Modified adenovirus containing a stabilized antibody |
| 05/26/2011 | US20110126326 Strong activation domain |
| 05/26/2011 | US20110126325 Recombinant cells and methods for hydroxylating fatty acids |
| 05/26/2011 | US20110126324 Hypervirulent mutant of agrobacterium tumefaciens |
| 05/26/2011 | US20110126323 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 05/26/2011 | US20110126322 Plant having resistance to low-temperature stress and method of production thereof. |
| 05/26/2011 | US20110126321 Recombinant dna for gene suppression |
| 05/26/2011 | US20110126320 Method for producing rose with altered petal colors |
| 05/26/2011 | US20110126318 Sucrose transporter genes for increasing plant seed lipids |
| 05/26/2011 | US20110126317 Plant viral expression vectors and use of same for generating genotypic variations in plant genomes |
| 05/26/2011 | US20110126316 Use of rice polypeptides/nucleic acids for plant improvement |
| 05/26/2011 | US20110126315 Novel selection marker gene and use thereof |
| 05/26/2011 | US20110126314 Modulation of coffee flavour precursor levels in green coffee grains |
| 05/26/2011 | US20110126313 Methods and compositions for modifying plant flavonoid composition and disease resistance |